Unknown

Dataset Information

0

[CMP] [cell line] [SIDM00249] Esophageal Squamous Cell Carcinoma

ABSTRACT:

SUBMITTER:  

PROVIDER: S-CMO303 | biostudies-other |

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Genomic characterization of a newly established esophageal squamous cell carcinoma cell line from China and published esophageal squamous cell carcinoma cell lines.
| S-EPMC7247234 | biostudies-literature
Unknown Gene expression profile of human esophageal squamous carcinoma cell line TE-1.
| S-EPMC4613095 | biostudies-literature
Unknown LEAP-014: first-line lenvatinib + pembrolizumab + chemotherapy in advanced/metastatic esophageal squamous cell carcinoma.
| S-EPMC11572187 | biostudies-literature
Unknown Immunotherapy for Esophageal Squamous Cell Carcinoma.
| S-EPMC5374168 | biostudies-literature
Genomics Esophageal squamous cell carcinoma WGS
| PRJNA511355 | ENA
Genomics Esophageal squamous cell carcinoma WGS1
| PRJNA511362 | ENA
Unknown Drug repositioning for esophageal squamous cell carcinoma.
| S-EPMC9554346 | biostudies-literature
Unknown Somatically Acquired LINE-1 Insertions in Normal Esophagus Undergo Clonal Expansion in Esophageal Squamous Cell Carcinoma.
| S-EPMC5548391 | biostudies-literature
Unknown A global perspective in second-line treatment patterns for patients with advanced esophageal squamous cell carcinoma.
| S-EPMC9058306 | biostudies-literature
Unknown Safety and tolerability of first-line durvalumab with tremelimumab and chemotherapy in esophageal squamous cell carcinoma.
| S-EPMC10469840 | biostudies-literature